Long-term treatment of homozygous familial hypercholesterolemia with lomitapide: 11 years of safety and effectiveness findings from the Lomitapide Observational Worldwide Evaluation Registry
Long-term treatment of homozygous familial hypercholesterolemia with lomitapide: 11 years of safety and effectiveness findings from the Lomitapide Observational Worldwide Evaluation Registry. // Journal of Clinical Lipidology. – URL: https://www.sciencedirect.com/science/article/pii/S1933287426004575?dgcid=rss_sd_all
Long-term treatment of homozygous familial hypercholesterolemia with lomitapide: 11 years of safety and effectiveness findings from the Lomitapide Observational Worldwide Evaluation Registry. Journal of Clinical Lipidology. https://www.sciencedirect.com/science/article/pii/S1933287426004575?dgcid=rss_sd_all
“Long-term treatment of homozygous familial hypercholesterolemia with lomitapide: 11 years of safety and effectiveness findings from the Lomitapide Observational Worldwide Evaluation Registry.” Journal of Clinical Lipidology.
@article{article53081,
title = {Long-term treatment of homozygous familial hypercholesterolemia with lomitapide: 11 years of safety and effectiveness findings from the Lomitapide Observational Worldwide Evaluation Registry},
journal = {Journal of Clinical Lipidology},
url = {https://www.sciencedirect.com/science/article/pii/S1933287426004575?dgcid=rss_sd_all}
}